• Sizzle Reel
  • Work
  • About
  • Aspiring
  • Contact
Damon Wong
  • Sizzle Reel
  • Work
  • About
  • Aspiring
  • Contact

Ibsrela

IBSRELA is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBS-C).

It works differently in comparison to competitors such as Linzess or Trulance by keeping water in the gut to help soften stool and help it move along. Their approach for treatment in IBS-C is a ‘not one size fits all’ simply because their treatment provides a therapy with a different mechanism of action, in a different class. Their competitors utilize a secretagogue approach where IBSRELA uses a retainagogue approach.

IBSRELA was very much in the concept / testing phase when I came on board. Once the ‘Flip the Script’ campaign was approved and established I worked with the team to create an array of collateral that ranged from video, print, conference booths, websites, and social. Since the campaign was being created while the work was being completed, we were essentially ‘building the plane as we flew it,’ but the end result was well worth it because the final Creative came out amazing.

PRINT_OFFICE_007.jpg
Slide1.jpeg
Slide1.jpeg
Slide2.jpeg
Slide3.jpeg
Slide4.jpeg
Slide2.jpeg
Slide3.jpeg
Fence_Billboard_Mockup_3.jpg
Fence_Billboard_Mockup_2.jpg
Fence_Billboard_Mockup_1.jpg
Screenshot 2024-10-23 at 2.31.05 PM.png
24IBRA5352 HCP Pain_and_bloating_brochure_v13_InStudio_Page_1.jpg
24IBRA5352 HCP Pain_and_bloating_brochure_v13_InStudio_Page_3.jpg
24IBRA5352 HCP Pain_and_bloating_brochure_v13_InStudio_Page_2.jpg
24IBRA5352 HCP Pain_and_bloating_brochure_v13_InStudio_Page_4.jpg
24IBRA5352 HCP Pain_and_bloating_brochure_v13_InStudio_Page_5.jpg
Slide8.jpeg
Screenshot 2024-10-23 at 1.07.24 PM.png
24IBRA5290_HCP_ACG_Registration_Panel_Workfront_DR_Page_2.jpg
24IBRA5290_HCP_ACG_Registration_Panel_Workfront_DR_Page_3.jpg
24IBRA5290_HCP_ACG_Registration_Panel_Workfront_DR_Page_4.jpg
24IBRA5290_HCP_ACG_Registration_Panel_Workfront_DR_Page_5.png
Screenshot 2024-10-23 at 1.07.54 PM.png
24IBRA5290_HCP_ACG_Registration_Panel_Workfront_DR_Page_7.jpg
24IBRA5290_HCP_ACG_Registration_Panel_Workfront_DR_Page_8.jpg
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_02.jpg
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_03.jpg
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_04.jpg
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_05.jpg
Screenshot 2024-10-23 at 1.38.30 PM.png
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_07.jpg
Screenshot 2024-10-23 at 1.38.14 PM.png
Screenshot 2024-10-23 at 1.45.45 PM.png
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_08.jpg
Screenshot 2024-10-23 at 1.46.02 PM.png
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_09.jpg
IXM_Adrelyx_41229400_ACG_2024_V3_KW_Page_10.jpg
PPT Divider Slides.jpg
01 FTS_Website.png
24IBRA4927_IBSrela HCP Website_v23_Page_01.jpg
24IBRA4927_IBSrela HCP Website_v23_Page_03.jpg
24IBRA4927_IBSrela HCP Website_v23_Page_04.jpg
24IBRA4927_IBSrela HCP Website_v23_Page_05.jpg
P2p_24IBRA4927 HCP Website Update (Phase 1) -101024_Page_1.jpg
24IBRA4927_IBSrela HCP Website_v23_Page_06.jpg
24IBRA4927_IBSrela HCP Website_v23_Page_07.jpg
P2p_24IBRA4927 HCP Website Update (Phase 1) -101024_Page_3.jpg
P2p_24IBRA4927 HCP Website Update (Phase 1) -101024_Page_2.jpg
Slide7.jpeg
Isbrela_dtp_site_v1_44_Page_01.jpg
Isbrela_dtp_site_v1_44_Page_02.jpg
Isbrela_dtp_site_v1_44_Page_03.jpg
Isbrela_dtp_site_v1_44_Page_04.jpg
Isbrela_dtp_site_v1_44_Page_05.jpg
Slide6.jpeg
24IBRA5031_Acquisition Brochure_DIGITAL_M4_Page_1.jpg
24IBRA5031_Acquisition Brochure_DIGITAL_M4_Page_2.jpg
24IBRA5031_Acquisition Brochure_DIGITAL_M4_Page_3.jpg
24IBRA5031_Acquisition Brochure_DIGITAL_M4_Page_4.jpg
24IBRA5031_Acquisition Brochure_DIGITAL_M4_Page_5.jpg
24IBRA5031_Acquisition Brochure_DIGITAL_M4_Page_6.jpg
Isbrela_dtp_site_v1_44_Page_06.jpg
Isbrela_dtp_site_v1_44_Page_07.jpg
Isbrela_dtp_site_v1_44_Page_08.jpg
Isbrela_dtp_site_v1_44_Page_09.jpg
Isbrela_dtp_site_v1_44_Page_10.jpg
Isbrela_dtp_site_v1_44_Page_11.jpg

Powered by Squarespace.